|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/74 | |
| C07D 213/75 | |||
| C07D 213/81 | |||
| C07D 213/82 | |||
| C07D 237/20 | |||
| C07D 239/42 | |||
| C07D 263/48 | |||
| C07D 277/42 | |||
| C07D 401/10 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 405/12 | |||
| C07D 413/10 | |||
| C07D 413/12 | |||
| A61K 31/44 | |||
| A61K 31/50 | |||
| A61K 31/53 | |||
| A61K 31/421 | |||
| A61K 31/426 |
| (11) | Number of the document | 2402319 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11158224.3 |
| Date of filing the European patent application | 2007-03-28 | |
| (97) | Date of publication of the European application | 2012-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 787859 P | 2006-03-31 | US |
| (72) |
Serrano-Wu, Michael H, US
Kwak, Young-Shin, US
Liu, Wenming, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DGAT Inhibitors |
| DGAT Inhibitors |